Moderna
MRNA
#275
Rank
A$125.82 B
Marketcap
A$315.15
Share price
-0.47%
Change (1 day)
634.61%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$125.82 Billion

As of October 2026 Moderna has a market cap of A$125.82 Billion. This makes Moderna the world's 275th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$125.82 B591.29%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Oct 30th, 2026 the market cap of Moderna was reported to be:

A$125.82 Billion
by Nasdaq info icon info icon
A$125.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$934.82 B 642.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$431.63 B 243.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$524.34 B 316.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.80 B-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.23 B-96.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.18 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$31.41 B-75.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$11.99 B-90.47%๐Ÿ‡บ๐Ÿ‡ธ USA